首页> 外文期刊>Anti-cancer agents in medicinal chemistry >The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
【24h】

The type II transmembrane serine protease, matriptase-2: Possible links to cancer?

机译:II型跨膜丝氨酸蛋白酶matriptase-2:可能与癌症有关?

获取原文
获取原文并翻译 | 示例
           

摘要

Matriptase-2 is a newly identified member of the Type II Transmembrane Serine Protease (TTSP) family. The expression profile of many members of this family of proteases is frequently altered in cancerous cells and tissues and a number of TTSPs have been linked to cancer progression and development. Matriptase-2 is structurally similar to matriptase-1, a TTSP which has gained recent interest due to its potential to enhance the aggressive nature of cancer cells and its links with a variety of human cancers. Recently, matriptase-2 has been functionally linked to the regulation of iron metabolism; however, there is also evidence to suggest that, as with other members of the TTSPs, matriptase-2 may have a role in cancer development and progression. This article reviews the current literature on matriptase-2, together with its potential roles in physiological and disease states particularly focusing on cancer.
机译:Matriptase-2是II型跨膜丝氨酸蛋白酶(TTSP)家族的新成员。该蛋白酶家族的许多成员的表达谱在癌细胞和组织中经常被改变,并且许多TTSP已经与癌症的进展和发展相关。 Matriptase-2在结构上类似于matriptase-1,后者是一种TTSP,由于其具有增强癌细胞的侵袭性及其与多种人类癌症的联系的潜力,因此最近受到了关注。最近,Matriptase-2在功能上与铁代谢的调节有关。然而,也有证据表明,与其他TTSP成员一样,matriptase-2可能在癌症的发生和发展中起作用。本文回顾了有关matriptase-2的最新文献,及其在生理和疾病状态中的潜在作用,尤其是针对癌症的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号